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tIn the preparation of this commentary, four separate
individuals with extensive publications, in particular, with
use of the Medicare database, independently reviewed the
article in question,1 and readers of JVS will note that it was
reviewed in the August 2012 Abstracts section of the
Journal. I note that the study in the above-referenced
article was supported by a grant from the Society of Inter-
ventional Radiology (SIR), and that the corresponding
author was, at the time of publication of the article, the SIR
President. Furthermore, the same individual continued to
malign vascular surgeons with respect to their endovascular
competence in his SIR presidential address, stating that “it
is impossible . . . to be a master of such disparate skills as
open revascularization and IR.”2 It is clear then that the
article in question is but a vehicle to promulgate this
prejudiced and self-serving point of view. The unfounded
accusation, stated in the article with respect to monetary
concerns motivating the practice of vascular surgeons (VS),
is repugnant to be included in a scientific publication. To
wit, the introductory paragraph states the authors’ mes-
sage, which is that VS offer endovascular procedures related
to economic greed. This theme is continued in the Discus-
sion section where the authors contend that vascular sur-
geons offering both open and endovascular procedures
represents an inherent conflict of interest, encompassing
some sinister plot that VS are perpetuating against Medi-
care beneficiaries to capture more revenue. This accusation
represents a perverse aberration of the facts in the practice
of vascular interventions. Since VS are the only specialists
offering both open and endovascular options to patients, it
must be apparent that VS make treatment recommenda-
Author conflict of interest: none.
The editors and reviewers of this article have no relevant financial relationships
to disclose per the JVS policy that requires reviewers to decline review of any
manuscript for which they may have a conflict of interest.
J Vasc Surg 2012;56:1105-6
0741-5214/$36.00“
Copyright © 2012 by the Society for Vascular Surgery.
http://dx.doi.org/10.1016/j.jvs.2012.08.046ions without prejudice or bias to any particular mode of
ntervention since they can perform both modalities.
As in other vascular territories, treatment of leg occlu-
ive disease has largely shifted from open to endovascular
rocedures, and Interventional Radiologists (IR) “market
hare” for such procedures declined from 67% in 1996 to
ess than 20% in 2006.3 Patients are best served when VS,
ho provide comprehensive care and longitudinal follow-
p, also perform their intervention, irrespective of its na-
ure. It is certainly true that the Society for Vascular Surgery
SVS) and others engineered a retraining of the VS work-
orce over the past 15 years. It is also true that in terms of
ndovascular training, the paradigm has shifted completely.
S trainees have had mandated endovascular training with
ase number requirements for a decade now, and their
xperience in this realm now far exceeds that of IR fellows.
The very structure of the study and its end points are
llogical. The selection of end points such as transfusion,
se of intensive care services, and length of stay are often
rrelevant (in hospitalized patients) to an endovascular pro-
edure per se; rather, they reflect the overall complexity
nd/or complicating patient comorbidities that may dom-
nate the clinical picture. Nor can the Medicare database
sed in this study discern the temporal relationship of end
oints such as intensive care unit stay to the vascular inter-
ention. These are the realities of clinical practice that only
hose involved in actual patient care can appreciate. In
onsideration of the mortality end point, the authors re-
eatedly call attention to the “19% higher mortality with
ascular surgeons” (data not shown), but they note this
ifference was not significant. In addition, the selection of a
ubsequent revascularization or amputation as a surrogate
or procedural quality is seriously flawed and introduces the
ingle glaring flaw in this article, viz the failure to include
pecifics of the indication for vascular intervention (ie,
hether the indication for intervention was claudication or
imb-threatening ischemia). These data are indeed available
n the Medicare database that the authors used, but we are
old that inclusion of such data in regression models were
less predictive and had a low R-square values.” The trans-
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October 20121106 Cambrialation, obviously, is that when adjusting for vascular disease
severity, the authors’ preconceived message was no longer
supported by the data. The authors’ attempt to manipulate
the data with illogical surrogates for procedural expertise
may be in response to prior work, using the Nationwide
Inpatient Sample database that demonstrated both proce-
dural mortality and iatrogenic arterial injury to be signifi-
cantly higher for IR and cardiologists as compared to VS.4
Indeed, this report also utilized appropriate risk adjusted
multivariate analyses, which is inherently lacking in the
Journal of Vascular and Interventional Radiology article.
Furthermore, it is well documented that VS are significantly
more likely to treat patients with rest pain and tissue loss
(limb-threatening ischemia) as compared to claudicants.5 It
is also documented and intuitively logical that virtually all
of the end points that the authors consider, including
mortality, length of stay, amputation rates, and overall
resource consumption, are significantly higher in patients
treated for limb-threatening ischemia as opposed to clau-
dication.6 The analysis was adjusted only for age, sex, race,
admission type, and a general comorbidity measure (Elix-
hauser method), which accounts for 30 variables including
irrelevant factors such as weight loss, hypothyroidism, and
paralysis but not for the indication for the procedure. Thus,
when used as a total score, this method includes a great deal
of “noise,” making it largely irrelevant to treatment out-
comes in patients with PAD. Such indices were developed
to be used at administrative levels in comparing hospital or
health systems rather than individual patient outcomes.
Multicollinearity is another problem that can lead to
biased estimates of the parameter standard errors. This
should have been tested for and fixed when it exists. Appar-
ently, this was not done during the analysis of the data in
this study. In addition, the authors made little attempt to
match cases across providers. The standard way is to use
propensity score matching. These scores should be derived
using risk models to predict provider type; this might have
allowed for a comparison of different provider types’ out-
comes when compared based on similar patients. This was
also not done. Therefore, it is rather surprising that the
authors (and reviewers) of this article appear to have ig-
nored the fact that a correlation is not the same as a cause.
Even if it had used the appropriate matching methods
described above, this is not a study that can establish a
causal relationship between provider type and outcomeince it is retrospective and utilized correlational data. As
oted above, patients do indeed differ across provider
ypes5; therefore, the conclusion that VS delivered worse
utcomes to Medicare patients reaches beyond what this
ype of study is capable of demonstrating, particularly in the
bsence of appropriate risk adjustment.
Finally, the use of the end point of repeat revasculariza-
ion or any amputation as the surrogate for quality of the
ndex procedure is patently absurd. A digital or forefoot
mputation is often performed subsequent to a lower ex-
remity revascularization in patients with tissue loss. Fur-
hermore, secondary interventions after infrainguinal endo-
ascular procedures are commonly required to maintain
econdary (reported ranges, 15-30%) patency.7
This article should be recognized as a self-serving slan-
er against VS, doubtlessly motivated by or in response to
he major shift in medical specialty provider demographics
or lower extremity endovascular interventions.3 The lack
f scientific and analytical rigor completely undermines the
alidity of its conclusions.
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